BPC-157 vs TB-500: The Wolverine peptide stack comparison
BPC-157 acts locally at the site of injury. TB-500 acts systemically through the bloodstream. Here is how bpc 157 and tb 500 compare, and why they're often combined into the Wolverine Stack.
Healing
bpc
Longevity
BPC-157
Preclinical
VS
tb5
TB-500
As seen on
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic, stable peptide fragment based on a protein found in human gastric juice, studied for its role in localized tissue repair.
Localized mechanism
A stable, synthetic fragment derived from human gastric juice, studied for angiogenesis and growth-factor activity at the site of an injury.
Best-studied use case
Gastrointestinal healing plus tendon and ligament research, where a concentrated, site-specific effect is the priority.
Research status
Not FDA-approved for human use and banned by WADA since 2022. Sold strictly for research purposes.
What Is TB-500?
TB-500 is a synthetic version of a fragment of Thymosin Beta-4, a protein that occurs naturally throughout the body, studied for its role in systemic recovery.
Systemic mechanism
A synthetic fragment of Thymosin Beta-4, studied for regulating actin, the protein that drives cell migration and blood vessel formation.
Wound healing and angiogenesis research where a whole-body, circulating effect is the priority, rather than one localized area.
BPC-157 vs TB-500 at a Glance
A feature-by-feature look at how bpc 157 and tb 500 differ across mechanism, dosing, and legal status.
BPC-157
Site of action (Localized)
Origin (Gastric juice fragment)
Supports angiogenesis
Typical research dose (200–500 mcg/day)
Typical frequency (1–2x daily)
Typical cycle length (4–6 weeks)
Subcutaneous injection
WADA-banned since 2022
Studied alone (no pairing required)
TB-500
Site of action (Systemic)
Origin (Thymosin Beta-4 fragment)
Regulates actin / cell migration
Typical research dose (2–5 mg/week)
Typical frequency (2–3x weekly)
Typical cycle length (4–8 weeks)
BPC-157Read the full profile
TB-500Read the full profile
Localized
Systemic
Gastric juice fragment
Thymosin Beta-4 fragment
Included for BPC-157
Included for TB-500
Not included for BPC-157
200–500 mcg/day
2–5 mg/week
1–2x daily
2–3x weekly
4–6 weeks
4–8 weeks
Not included for TB-500
Our top-rated vendor
View all vendors
Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.
Based on current scores, this vendor ranks highest across those criteria.
Protide Health
#1 Rated Research Peptide Supplier
Comparison at a Glance: BPC-157 vs TB-500
A quick side-by-side look at how bpc 157 and tb 500 differ across mechanism, dosing, cycle length, and legal status.
Site of action
BPC-157 concentrates its effect at the local site of injury. TB-500 circulates systemically through the bloodstream.
Typical research dose
BPC-157 is commonly dosed at 200 to 500 mcg per day. TB-500 is commonly dosed at 2 to 5 mg per week.
Typical cycle length
BPC-157 protocols often run 4 to 6 weeks. TB-500 protocols often run 4 to 8 weeks, then reassess.
Legal and administration
Neither is FDA-approved for human use; both are WADA-banned. Both are most commonly injected subcutaneously in research use.
Wolverine Blend (BPC-157, TB-500) Dosage Guide for Recovery & RepairWolverine Blend (BPC-157, TB-500) Dosage Calculator
This combines BPC-157 and TB-500, two well-known healing peptides, to speed up tissue recovery from injuries.
Vial size
10 mg
Bacteriostatic water
2 mL
Dosing
250–500 mcg
Frequency
Daily
Cycle
4–8 weeks
Benefit
Recovery & Repair
Why It's Called the Wolverine Stack
BPC-157 and TB-500 are frequently combined into what researchers nickname the Wolverine Stack, pairing a localized healer with a systemic one in a single protocol.
A nod to rapid regeneration
The pairing earned the nickname Wolverine Stack as a reference to the Marvel character's rapid regenerative healing, not a scientific or regulatory term.
Local plus systemic
BPC-157 concentrates at the injury site while TB-500 supports recovery throughout the body at the same time, which is why the two are combined rather than used alone.
Not an approved treatment
The Wolverine Stack is a research and discussion term, not a clinical protocol. Neither compound is FDA-approved for human use.
Frequently Asked Questions: BPC-157 vs TB-500
Straight answers on how BPC-157 and TB-500 compare, how the Wolverine Stack works, and how to dose the blend. For research reference only.
Are BPC-157 and TB-500 the same?
No. BPC-157 and TB-500 are two different peptides with different origins and mechanisms. BPC-157 is a stable, synthetic fragment derived from a protein found in human gastric juice, and it appears to act mostly at the local site of injury. TB-500 is a synthetic version of a fragment of Thymosin Beta-4, a naturally occurring protein, and it works systemically by regulating actin and supporting cell migration throughout the body. They are frequently studied and used together, but they are not interchangeable.
Which peptide does Joe Rogan take?
Joe Rogan has publicly discussed using BPC-157, primarily in the context of joint and injury recovery, and has referenced combining it with TB-500 as part of a broader recovery stack. This page does not endorse or verify any specific individual's protocol. Both compounds discussed here are intended for research purposes only.
Is BPC-157 effective without TB-500?
BPC-157 is studied on its own in a large share of the available research and is not dependent on TB-500 to have an effect. Because BPC-157's proposed mechanism centers on localized angiogenesis and growth-factor modulation at the site of injury, many research protocols use it alone for tendon, ligament, or gastrointestinal-focused work. TB-500 is typically added when a protocol also wants systemic, whole-body support, not because BPC-157 requires it to function.
Can BPC-157 cause liver damage?
Current published research has not established that BPC-157 causes liver damage, and some animal studies have instead explored protective effects on the liver. Human safety data remains limited, BPC-157 is not FDA-approved for human use, and any research-grade compound carries unknown risks, especially from unregulated sourcing or incorrect dosing. Review the current research directly and talk to a healthcare provider rather than relying on anecdotal claims.
How do you dose BPC-157 and TB-500 together?
Most research protocols anchor the blend to BPC-157, dosed daily, and calculate the TB-500 volume against that same draw using the fixed ratio in the vial. Use a blend dosage calculator to enter your vial size, water volume, and target dose, and get an exact draw volume instead of estimating from a prose range.
How often do people inject BPC-157 and TB-500?
In most published protocols, BPC-157 is dosed once or twice daily, while TB-500 is dosed less frequently, often two to three times per week, since it is understood to act more systemically and build up over a longer window. Frequency should always be based on the specific research protocol and vial concentration being used.
How do you mix a BPC-157 and TB-500 blend?
A BPC-157 and TB-500 blend is reconstituted the same way as a single-peptide vial: add bacteriostatic water slowly down the side of the vial, then gently swirl (never shake) until fully dissolved. Because a blend vial contains both peptides in a fixed ratio, the water volume you choose changes the concentration of both compounds together, so plan your draw volume with a blend-specific calculator.
How long is a typical BPC-157 and TB-500 cycle?
Cycle length varies by protocol and by the specific injury or goal being researched, but many write-ups describe cycles in the range of four to eight weeks, sometimes extended for deeper connective-tissue work and followed by a break before repeating.
What is Thymosin Beta-4 and how does it relate to TB-500?
Thymosin Beta-4 is the naturally occurring protein that TB-500 is derived from. TB-500 is a shorter, synthetic peptide fragment built around Thymosin Beta-4's active region, designed to reproduce its actin-regulating, cell-migration effects in a smaller, more stable molecule.
Is BPC-157 or TB-500 FDA approved?
Neither BPC-157 nor TB-500 is approved by the FDA for human use. Both are sold strictly as research chemicals, not for human consumption, and both were added to the World Anti-Doping Agency's (WADA) list of prohibited substances in 2022.
Stacking BPC-157 and TB-500: Dosing Basics
Most research write-ups anchor the blend to BPC-157, dosed daily, and layer TB-500 on a less frequent schedule since it acts more systemically and builds up over a longer window.
Anchor to BPC-157
Most protocols dose BPC-157 daily and calculate the TB-500 volume against that same draw, rather than dosing each peptide on a separate schedule.
Fixed blend ratio
In a combined vial, the ratio between BPC-157 and TB-500 is fixed at manufacture, so the water volume you add changes both concentrations at once.
Use a blend-specific calculator
A single-peptide calculator will not account for a fixed-ratio blend. Use a blend dosage calculator to get an accurate draw volume for both compounds.
Recovery Timeline: What to Expect Week by Week
Timelines vary by individual, injury type, and protocol, but many research write-ups describe a similar general pattern.
Weeks 1 to 2
Research write-ups commonly describe an early reduction in localized pain and inflammation as BPC-157's effect at the injury site takes hold.
Weeks 4 to 8
This window is typically associated with the bulk of structural tissue healing, as both peptides continue supporting the repair process.
Weeks 8 to 12
Many protocols describe a fuller recovery by this stage, with cycles concluding or moving into a maintenance and reassessment phase.
Free Downloadable Peptide Dosage Cheat Sheets
Reference dosage data for 100+ peptides is pre-loaded in these free cheat sheets, including common research stacks like the wolverine stack (BPC-157 + TB-500), MOTS-C, Retatrutide, and Semaglutide. Select a cheat sheet to see reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.
16 peptides
13 peptides
18 peptides
5 peptides
15 peptides